Literature DB >> 18522901

The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism.

Irmgard Paris1, Jorge Lozano, Sergio Cardenas, Carolina Perez-Pastene, Katherine Saud, Patricio Fuentes, Pablo Caviedes, Alexies Dagnino-Subiabre, Rita Raisman-Vozari, Takeshi Shimahara, John P Kostrzewa, David Chi, Richard M Kostrzewa, Raul Caviedes, Juan Segura-Aguilar.   

Abstract

RCSN-3 cells are a cloned cell line derived from the substantia nigra of an adult rat. The cell line grows in monolayer and does not require differentiation to express catecholaminergic traits, such as (i) tyrosine hydroxylase; (ii) dopamine release; (iii) dopamine transport; (iv) norepinephrine transport; (v) monoamine oxidase (MAO)-A expression, but not MAO-B; (vi) formation of neuromelanin; (vii) VMAT-2 expression. In addition, this cell line expresses serotonin transporters, divalent metal transporter, DMT1, dopamine receptor 1 mRNA under proliferating conditions, and dopamine receptor 5 mRNA after incubation with dopamine or dicoumarol. Expression of dopamine receptors D(2), D(3) and D(4) mRNA were not detected in proliferating cells or when the cells were treated with dopamine, CuSO(4), dicoumarol or dopamine-copper complex. Angiotensin II receptor mRNA was also found to be expressed, but it underwent down regulation in the presence of aminochrome. Total quinone reductase activity corresponded 94% to DT-diaphorase. The cells also express antioxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase. This cell line is a suitable in vitro model for studies of dopamine metabolism, since under proliferating conditions the cells express all the pertinent markers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522901     DOI: 10.1007/BF03033505

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  29 in total

1.  Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome.

Authors:  A Dagnino-Subiabre; K Marcelain; C Arriagada; I Paris; P Caviedes; R Caviedes; J Segura-Aguilar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.

Authors:  Irmgard Paris; Pedro Martinez-Alvarado; Carolina Perez-Pastene; Marcelo N N Vieira; Claudio Olea-Azar; Rita Raisman-Vozari; Sergio Cardenas; Rebeca Graumann; Pablo Caviedes; Juan Segura-Aguilar
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

Review 3.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

4.  Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.

Authors:  Irmgard Paris; Pedro Martinez-Alvarado; Sergio Cárdenas; Carolina Perez-Pastene; Rebecca Graumann; Patricio Fuentes; Claudio Olea-Azar; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2005-03       Impact factor: 3.739

5.  Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.

Authors:  C Massicotte; K Knight; C J Van der Schyf; B S Jortner; M Ehrich
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Calcium fluxes, ion currents and dihydropyridine receptors in a new immortal cell line from rat heart muscle.

Authors:  P Caviedes; E Olivares; K Salas; R Caviedes; E Jaimovich
Journal:  J Mol Cell Cardiol       Date:  1993-07       Impact factor: 5.000

7.  Differential regulation of the imipramine-sensitive serotonin transporter by cAMP in human JAr choriocarcinoma cells, rat PC12 pheochromocytoma cells, and C33-14-B1 transgenic mouse fibroblast cells.

Authors:  S C King; A A Tiller; A S Chang; D M Lam
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

8.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.

Authors:  Patricio Fuentes; Irmgard Paris; Melissa Nassif; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2007-04-11       Impact factor: 3.739

10.  Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.

Authors:  Keith Chiasson; Benoît Daoust; Daniel Levesque; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.978

View more
  11 in total

1.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

2.  Mitochondrial DNA damage initiates a cell cycle arrest by a Chk2-associated mechanism in mammalian cells.

Authors:  Christopher A Koczor; Inna N Shokolenko; Amy K Boyd; Shawn P Balk; Glenn L Wilson; Susan P LeDoux
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

3.  DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.

Authors:  Patricia Muñoz; Sergio Cardenas; Sandro Huenchuguala; Andrea Briceño; Eduardo Couve; Irmgard Paris; Juan Segura-Aguilar
Journal:  Toxicol Sci       Date:  2015-01-28       Impact factor: 4.849

4.  DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.

Authors:  Patricia S Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2017-05-06       Impact factor: 3.911

5.  Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.

Authors:  Irmgard Paris; Patricia Muñoz; Sandro Huenchuguala; Eduardo Couve; Laurie H Sanders; John Timothy Greenamyre; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Toxicol Sci       Date:  2011-04-06       Impact factor: 4.849

6.  Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.

Authors:  Patricia Muñoz; Sandro Huenchuguala; Irmgard Paris; Carlos Cuevas; Monica Villa; Pablo Caviedes; Juan Segura-Aguilar; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-04-12       Impact factor: 3.911

7.  One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.

Authors:  Monica Villa; Patricia Muñoz; Ulises Ahumada-Castro; Irmgard Paris; Ana Jiménez; Isabel Martínez; Francisca Sevilla; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Eduardo Couve; Pablo Caviedes; Susan Ledoux; Juan Segura-Aguilar
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

9.  Molecular and neurochemical mechanisms in PD pathogenesis.

Authors:  Irmgard Paris; Jorge Lozano; Carolina Perez-Pastene; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2009-05-20       Impact factor: 3.911

10.  Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites.

Authors:  Andres Binolfi; Antonio Limatola; Silvia Verzini; Jonas Kosten; Francois-Xavier Theillet; Honor May Rose; Beata Bekei; Marchel Stuiver; Marleen van Rossum; Philipp Selenko
Journal:  Nat Commun       Date:  2016-01-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.